Erstellt von fchar99
Insmed Inc. diskutieren
Insmed Inc.
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
165,00 €
-0,60 %
Insmed (NASDAQ:INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $121.00 to $196.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $171.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target raised by analysts at Bank of America Corporation from $142.00 to $187.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $192.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target raised by analysts at TD Cowen from $223.00 to $231.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) was given a new $256.00 price target on by analysts at Mizuho. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $263.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target raised by analysts at TD Cowen from $231.00 to $269.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Weight Watchers International diskutieren